CLINICAL_TRIALS
trial_result
· 2023-09-21
Clinical Trial Update: The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease [NA]
Summary
A completed clinical trial evaluating the effect of lanthanum carbonate on FGF23 levels in chronic kidney disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Endeavor Health | Conditions: Metabolic Bone Disease | NA | Status: COMPLETED | Results posted: 2023-09-21